vs

Side-by-side financial comparison of PTC THERAPEUTICS, INC. (PTCT) and VINCE HOLDING CORP. (VNCE). Click either name above to swap in a different company.

PTC THERAPEUTICS, INC. is the larger business by last-quarter revenue ($164.7M vs $85.1M, roughly 1.9× VINCE HOLDING CORP.). VINCE HOLDING CORP. runs the higher net margin — 3.2% vs -82.0%, a 85.2% gap on every dollar of revenue. On growth, VINCE HOLDING CORP. posted the faster year-over-year revenue change (6.2% vs -22.7%). VINCE HOLDING CORP. produced more free cash flow last quarter ($-5.7M vs $-36.6M). Over the past eight quarters, VINCE HOLDING CORP.'s revenue compounded faster (6.3% CAGR vs -11.5%).

PTC Therapeutics, Inc. is a US pharmaceutical company focused on the development of orally administered small molecule drugs and gene therapy which regulate gene expression by targeting post-transcriptional control (PTC) mechanisms in orphan diseases.

VINCE. is a contemporary clothing fashion brand founded in 2002. In 2023 Authentic Brands Group purchased its intellectual property in a $76.5 million deal.

PTCT vs VNCE — Head-to-Head

Bigger by revenue
PTCT
PTCT
1.9× larger
PTCT
$164.7M
$85.1M
VNCE
Growing faster (revenue YoY)
VNCE
VNCE
+28.9% gap
VNCE
6.2%
-22.7%
PTCT
Higher net margin
VNCE
VNCE
85.2% more per $
VNCE
3.2%
-82.0%
PTCT
More free cash flow
VNCE
VNCE
$30.9M more FCF
VNCE
$-5.7M
$-36.6M
PTCT
Faster 2-yr revenue CAGR
VNCE
VNCE
Annualised
VNCE
6.3%
-11.5%
PTCT

Income Statement — Q4 FY2025 vs Q3 FY2026

Metric
PTCT
PTCT
VNCE
VNCE
Revenue
$164.7M
$85.1M
Net Profit
$-135.0M
$2.7M
Gross Margin
49.2%
Operating Margin
-43.3%
6.4%
Net Margin
-82.0%
3.2%
Revenue YoY
-22.7%
6.2%
Net Profit YoY
-104.8%
-37.3%
EPS (diluted)
$-1.63
$0.21

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PTCT
PTCT
VNCE
VNCE
Q4 25
$164.7M
$85.1M
Q3 25
$211.0M
$73.2M
Q2 25
$178.9M
$57.9M
Q1 25
$1.2B
$80.0M
Q4 24
$213.2M
$80.2M
Q3 24
$196.8M
$74.2M
Q2 24
$186.7M
$59.2M
Q1 24
$210.1M
$75.3M
Net Profit
PTCT
PTCT
VNCE
VNCE
Q4 25
$-135.0M
$2.7M
Q3 25
$15.9M
$12.1M
Q2 25
$-64.8M
$-4.8M
Q1 25
$866.6M
$-28.3M
Q4 24
$-65.9M
$4.3M
Q3 24
$-106.7M
$569.0K
Q2 24
$-99.2M
$4.4M
Q1 24
$-91.6M
$-4.7M
Gross Margin
PTCT
PTCT
VNCE
VNCE
Q4 25
49.2%
Q3 25
50.4%
Q2 25
50.3%
Q1 25
50.1%
Q4 24
50.0%
Q3 24
47.4%
Q2 24
50.6%
Q1 24
45.4%
Operating Margin
PTCT
PTCT
VNCE
VNCE
Q4 25
-43.3%
6.4%
Q3 25
1.4%
15.2%
Q2 25
-19.5%
-7.7%
Q1 25
82.5%
-37.1%
Q4 24
-76.2%
7.2%
Q3 24
-27.7%
1.5%
Q2 24
-21.5%
9.5%
Q1 24
-21.6%
-2.2%
Net Margin
PTCT
PTCT
VNCE
VNCE
Q4 25
-82.0%
3.2%
Q3 25
7.5%
16.5%
Q2 25
-36.3%
-8.3%
Q1 25
73.7%
-35.5%
Q4 24
-30.9%
5.4%
Q3 24
-54.2%
0.8%
Q2 24
-53.1%
7.4%
Q1 24
-43.6%
-6.2%
EPS (diluted)
PTCT
PTCT
VNCE
VNCE
Q4 25
$-1.63
$0.21
Q3 25
$0.20
$0.93
Q2 25
$-0.83
$-0.37
Q1 25
$10.04
$-2.25
Q4 24
$-0.85
$0.34
Q3 24
$-1.39
$0.05
Q2 24
$-1.29
$0.35
Q1 24
$-1.20
$-0.37

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PTCT
PTCT
VNCE
VNCE
Cash + ST InvestmentsLiquidity on hand
$1.9B
$1.1M
Total DebtLower is stronger
Stockholders' EquityBook value
$-205.3M
$53.4M
Total Assets
$2.9B
$246.0M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PTCT
PTCT
VNCE
VNCE
Q4 25
$1.9B
$1.1M
Q3 25
$1.7B
$777.0K
Q2 25
$2.0B
$2.6M
Q1 25
$2.0B
$607.0K
Q4 24
$1.1B
$892.0K
Q3 24
$1.0B
$711.0K
Q2 24
$1.1B
$739.0K
Q1 24
$884.8M
$357.0K
Stockholders' Equity
PTCT
PTCT
VNCE
VNCE
Q4 25
$-205.3M
$53.4M
Q3 25
$-155.8M
$49.3M
Q2 25
$-206.5M
$37.2M
Q1 25
$-185.8M
$41.8M
Q4 24
$-1.1B
$57.1M
Q3 24
$-1.1B
$52.4M
Q2 24
$-980.2M
$51.7M
Q1 24
$-893.9M
$47.2M
Total Assets
PTCT
PTCT
VNCE
VNCE
Q4 25
$2.9B
$246.0M
Q3 25
$2.6B
$239.0M
Q2 25
$2.6B
$218.0M
Q1 25
$2.7B
$222.7M
Q4 24
$1.7B
$254.7M
Q3 24
$1.8B
$253.6M
Q2 24
$1.9B
$223.1M
Q1 24
$1.8B
$225.1M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PTCT
PTCT
VNCE
VNCE
Operating Cash FlowLast quarter
$-34.3M
$-5.1M
Free Cash FlowOCF − Capex
$-36.6M
$-5.7M
FCF MarginFCF / Revenue
-22.3%
-6.7%
Capex IntensityCapex / Revenue
1.4%
0.7%
Cash ConversionOCF / Net Profit
-1.86×
TTM Free Cash FlowTrailing 4 quarters
$702.3M
$4.3M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PTCT
PTCT
VNCE
VNCE
Q4 25
$-34.3M
$-5.1M
Q3 25
$-66.3M
$4.2M
Q2 25
$-58.3M
$-11.8M
Q1 25
$870.1M
$22.7M
Q4 24
$-30.0M
$6.4M
Q3 24
$-77.0M
$-3.2M
Q2 24
$-71.5M
$-3.9M
Q1 24
$70.8M
$14.8M
Free Cash Flow
PTCT
PTCT
VNCE
VNCE
Q4 25
$-36.6M
$-5.7M
Q3 25
$-69.7M
$2.1M
Q2 25
$-59.6M
$-13.2M
Q1 25
$868.4M
$21.2M
Q4 24
$-33.8M
$5.1M
Q3 24
$-77.5M
$-3.9M
Q2 24
$-78.8M
$-4.6M
Q1 24
$61.2M
$14.2M
FCF Margin
PTCT
PTCT
VNCE
VNCE
Q4 25
-22.3%
-6.7%
Q3 25
-33.1%
2.9%
Q2 25
-33.3%
-22.9%
Q1 25
73.8%
26.5%
Q4 24
-15.8%
6.4%
Q3 24
-39.4%
-5.2%
Q2 24
-42.2%
-7.8%
Q1 24
29.1%
18.9%
Capex Intensity
PTCT
PTCT
VNCE
VNCE
Q4 25
1.4%
0.7%
Q3 25
1.6%
2.9%
Q2 25
0.7%
2.5%
Q1 25
0.1%
1.9%
Q4 24
1.8%
1.6%
Q3 24
0.3%
0.9%
Q2 24
4.0%
1.3%
Q1 24
4.6%
0.7%
Cash Conversion
PTCT
PTCT
VNCE
VNCE
Q4 25
-1.86×
Q3 25
-4.17×
0.35×
Q2 25
Q1 25
1.00×
Q4 24
1.48×
Q3 24
-5.61×
Q2 24
-0.89×
Q1 24

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PTCT
PTCT

Segment breakdown not available.

VNCE
VNCE

Vince Wholesale$52.0M61%
Vince Direct To Consumer$33.1M39%

Related Comparisons